The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 26, 2021

Filed:

Jan. 30, 2013
Applicants:

Katholieke Universiteit Leuven, Leuven, BE;

Life Sciences Research Partners Vzw, Leuven, BE;

Inventor:

Jean-Marie Saint-Remy, Grez-Doiceau, BE;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/10 (2006.01); A61K 38/16 (2006.01); A61K 39/00 (2006.01); C12N 5/0783 (2010.01); C07K 7/08 (2006.01); A61K 39/04 (2006.01); A61K 39/35 (2006.01); C07K 14/47 (2006.01); C07K 14/435 (2006.01); A61K 35/17 (2015.01); A61K 38/17 (2006.01); A61K 39/145 (2006.01);
U.S. Cl.
CPC ...
C07K 7/08 (2013.01); A61K 35/17 (2013.01); A61K 39/04 (2013.01); A61K 39/35 (2013.01); C07K 14/43531 (2013.01); C07K 14/4713 (2013.01); C12N 5/0637 (2013.01); A61K 38/1709 (2013.01); A61K 38/1767 (2013.01); A61K 39/0011 (2013.01); A61K 39/145 (2013.01); A61K 2039/572 (2013.01); C12N 2501/05 (2013.01); C12N 2760/16122 (2013.01);
Abstract

The present invention relates to immunogenic peptides comprising a T-cell epitope. Said peptides are modified such that CD4+ T-cell responses are obtainable that are much stronger than the CD4+ T-cell responses obtained with the same peptides not comprising said modification. In particular, the modification is the addition of a cysteine, insertion of a cysteine or mutation into a cysteine of a residue at a position adjacent to but outside the MHC-binding site of the peptide. Further disclosed are the use of such modified peptides in treating, suppressing or preventing diseases such as infectious or allergic diseases and autoimmune diseases, in preventing or suppressing graft rejection, or in the eradication of tumor cells.


Find Patent Forward Citations

Loading…